首页> 外国专利> NOVEL COMPOUNDS CAPABLE OF ANTAGONIZING ISLET AMYLOID POLYPEPTIDE(IAPP) INDUCED BETA-CELL DAMAGE AND IMPAIRED GLUCOSE TOLERANCE

NOVEL COMPOUNDS CAPABLE OF ANTAGONIZING ISLET AMYLOID POLYPEPTIDE(IAPP) INDUCED BETA-CELL DAMAGE AND IMPAIRED GLUCOSE TOLERANCE

机译:能够拮抗胰岛淀粉样蛋白多肽(IAPP)诱导β细胞损伤和葡萄糖耐量受损的新化合物

摘要

A molecule that specifically binds to human islet amyloid polypeptide (hIAPP), also known as amylin, in particular islet amyloid polypeptide (IAPP), a condition typically associated with type 2 diabetes (T2D) induced β-cell injury and impaired glucose Human-derived antibodies for antagonizing resistance as well as fragments, derivatives and variants thereof are described.
机译:特异性结合人胰岛淀粉样蛋白多肽(HIAPP)的分子,也称为淀粉蛋白,特别是胰岛淀粉样蛋白多肽(IAPP),通常与2型糖尿病(T2D)诱导的β细胞损伤和葡萄糖人衍生的病症 描述了用于拮抗抗性的抗体以及其片段,衍生物及其变体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号